ReShape Lifesciences regains Nasdaq compliance
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 27 2025
0mins
Source: SeekingAlpha
Compliance Achievement: ReShape Lifesciences has successfully met Nasdaq's requirement of maintaining at least $2.5 million in stockholders’ equity.
Company Updates: The company provided earnings highlights and a strategic business update during a recent conference.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
